Inventor · disambiguated record
Stefan De Buck
Also filed as: DE BUCK STEFAN
7 granted patents·7 pending applications·15 citations·filing 2009–2025
79Inventor score
Files withNOVARTIS AG5ABLYNX NV4MEREO BIOPHARMA 1 LTD3BOUCHE MARIE-PAULE LUCIENNE ARMANDA1HOFFMANN LA ROCHE1
Top patents by PatentIndex Score
14 records- 0188US10603306B2Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2016·Granted Mar 31, 2020·5 cites·20 claims
- 0283US9320792B2Pulmonary administration of immunoglobulin single variable domains and constructs thereofABLYNX NV·Filed 2013·Granted Apr 26, 2016·4 cites·6 claims
- 0381US9725522B2Pulmonary administration of immunoglobulin single variable domains and constructs thereofABLYNX NV·Filed 2016·Granted Aug 8, 2017·2 cites·7 claims
- 0478US10617674B2Dosage regimen for the treatment of acute exacerbations of inflammatory conditionsMEREO BIOPHARMA 1 LTD·Filed 2016·Granted Apr 14, 2020·4 cites·16 claims
- 0562US2011158996A1Von willebrand factor specific binders and methods of use thereforABLYNX NV·Filed 2009·Application pending·0 cites
- 0660US2025375446A1Methods of treating chronic spontaneous urticaria using a bruton's tyrosine kinase inhibitorNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0759US11129810B2Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2020·Granted Sep 28, 2021·0 cites·16 claims
- 0857US2025339428A1Methods of treating sjogren's syndrome using a bruton's tyrosine kinase inhibitorNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0953US12419889B2Methods of treating chronic spontaneous urticaria using a bruton's tyrosine kinase inhibitorNOVARTIS AG·Filed 2020·Granted Sep 23, 2025·0 cites·30 claims
- 1052US12383556B2Methods of treating Sjögren's syndrome using a Bruton's tyrosine kinase inhibitorNOVARTIS AG·Filed 2020·Granted Aug 12, 2025·0 cites·21 claims
- 1149US2014044710A1Von willebrand factor specific binders and methods of use thereforABLYNX NV·Filed 2013·Application pending·0 cites
- 1249US2021069204A1Dosage of baloxavir marboxil for pediatric patientsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1336US2019038628A1Use of inhibitors of the activity or function of pi3k for the treatment of primary sjogren's syndromeNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1433US2011311515A1Pulmonary administration of immunoglobulin single variable domains and constructs thereofBOUCHE MARIE-PAULE LUCIENNE ARMANDA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →